IBB
$209.34+1.31%1DiShares Biotechnology ETF
AUM
$10.47B
Expense ratio
0.44%
Yield TTM
0.01%
Provider
iShares
Exchange
NASDAQ Global Market
About IBB
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
iShares Biotechnology ETF · Issued by iShares
Total return
1W
+1.10%
1M
-3.26%
3M
+11.74%
6M
+30.53%
YTD
+24.15%
1Y
+48.09%
3Y
+72.66%
5Y
+24.34%
10Y
+118.73%
Price - IBB
Full chart →Top 10 holdings
| AMGN | Amgen Inc | 8.45% |
| VRTX | Vertex Pharmaceuticals Inc | 8.06% |
| GILD | Gilead Sciences Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 5.72% |
| ARGX | argenx SE ADR | 3.80% |
| MRNA | Moderna Inc | 3.62% |
| NTRA | Natera Inc | 3.12% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| ILMN | Illumina Inc | 2.29% |
| ALNY | Alnylam Pharmaceuticals Inc | 2.27% |
Sector breakdown
Healthcare100.00%
Composition flow
Latest news - IBB
Elon Musk's Boring Company Is Raising Money at a $20 Billion Valuation. Here's How His Empire Outside Tesla Is Growing.The Boring Company is reportedly raising $4 billion at a $20 billion valuation -- nearly four times its 2022 price tag -- as its Vegas Loop prepares to expand to the airport. Neuralink's brain-computer interface is now implanted in 21 patients, and the company is targeting $1 billion in annual revenue by 2031, pending FDA approval.
The Motley Fool · 1mo agoHealthcareElectric Vehicles
Key statistics
Price$209.34
Change (1D)+1.31%
Volume—
AUM$10.47B
Expense ratio0.44%
Yield TTM0.01%
ProvideriShares
CurrencyUSD
ExchangeNASDAQ Global Market
SectorHealthcare
YTD+24.15%
1Y+48.09%